Loading…
Receptor protein tyrosine phosphatases and cancer: New insights from structural biology
There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion...
Saved in:
Published in: | Cell adhesion & migration 2012-07, Vol.6 (4), p.356-364 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193 |
container_end_page | 364 |
container_issue | 4 |
container_start_page | 356 |
container_title | Cell adhesion & migration |
container_volume | 6 |
creator | Nikolaienko, Roman M. Agyekum, Boadi Bouyain, Samuel |
description | There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression. |
doi_str_mv | 10.4161/cam.21242 |
format | article |
fullrecord | <record><control><sourceid>proquest_lande</sourceid><recordid>TN_cdi_landesbioscience_primary_celladhesion_article_21242_10_4161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1082409773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</originalsourceid><addsrcrecordid>eNqlkkuLFDEUhYMozji68A9ILXXRY16dVFwIY-MLWoRB1yGV3NiRqqRM0kr_e-PUTOPgQtBVAjnnu-cegtBjgs85EeS5NdM5JZTTO-iUKMZWQlFx93gn_Ql6UMpXjNc9EeI-OqFUKqE4PUXkEizMNeVuzqlCiF095FRChG7epTLvTDUFSmei66yJFvJDdM-bscCj6_MMfX7z-tPm3Wr78e37zcV2ZddC1JVT3nHppeR87bGVXkAvGeZEcq8s8N71hg4tp5LGgmdMDQwII8QNQtKW_Ay9XLjzfpjAWYg1m1HPOUwmH3QyQd9-iWGnv6TvmnHZ03XfAE-vATl920OpegrFwjiaCGlfNME95VhJyZr02SK1bfeSwR_HEKx_Vaxbxfqq4qZ98nuuo_Km0yZ4tQjaIAdlCKnYAK26o_QqhNtBCSlqk2uwIyz0m3kNsv1vyK3QL_4Z18zkL2aKCd1cfMBY4kuiZ-ebhy-eEH3Kk_mR8uh0NYcxZZ_bRwpFsz9z_gTqKuLh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1082409773</pqid></control><display><type>article</type><title>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</title><source>PubMed Central</source><creator>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</creator><creatorcontrib>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</creatorcontrib><description>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</description><identifier>ISSN: 1933-6918</identifier><identifier>EISSN: 1933-6926</identifier><identifier>DOI: 10.4161/cam.21242</identifier><identifier>PMID: 22796942</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Animals ; Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; cell adhesion ; Cell Communication ; crystal structure ; Cycle ; Gene Expression ; Humans ; inactivating somatic mutations ; Landes ; Models, Molecular ; Mutation ; Neoplasms - enzymology ; Neoplasms - genetics ; Neoplasms - pathology ; oncogene ; Organogenesis ; phosphatase ; phosphorylation ; Protein Interaction Domains and Motifs ; Protein Structure, Quaternary ; Proteins ; receptor overexpression ; receptor protein tyrosine phosphatase ; Receptor-Like Protein Tyrosine Phosphatases - chemistry ; Receptor-Like Protein Tyrosine Phosphatases - genetics ; Receptor-Like Protein Tyrosine Phosphatases - metabolism ; Review ; tumor suppressor</subject><ispartof>Cell adhesion & migration, 2012-07, Vol.6 (4), p.356-364</ispartof><rights>Copyright © 2012 Landes Bioscience 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478258/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478258/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22796942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nikolaienko, Roman M.</creatorcontrib><creatorcontrib>Agyekum, Boadi</creatorcontrib><creatorcontrib>Bouyain, Samuel</creatorcontrib><title>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</title><title>Cell adhesion & migration</title><addtitle>Cell Adh Migr</addtitle><description>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</description><subject>Animals</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>cell adhesion</subject><subject>Cell Communication</subject><subject>crystal structure</subject><subject>Cycle</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>inactivating somatic mutations</subject><subject>Landes</subject><subject>Models, Molecular</subject><subject>Mutation</subject><subject>Neoplasms - enzymology</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>oncogene</subject><subject>Organogenesis</subject><subject>phosphatase</subject><subject>phosphorylation</subject><subject>Protein Interaction Domains and Motifs</subject><subject>Protein Structure, Quaternary</subject><subject>Proteins</subject><subject>receptor overexpression</subject><subject>receptor protein tyrosine phosphatase</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - chemistry</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - genetics</subject><subject>Receptor-Like Protein Tyrosine Phosphatases - metabolism</subject><subject>Review</subject><subject>tumor suppressor</subject><issn>1933-6918</issn><issn>1933-6926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqlkkuLFDEUhYMozji68A9ILXXRY16dVFwIY-MLWoRB1yGV3NiRqqRM0kr_e-PUTOPgQtBVAjnnu-cegtBjgs85EeS5NdM5JZTTO-iUKMZWQlFx93gn_Ql6UMpXjNc9EeI-OqFUKqE4PUXkEizMNeVuzqlCiF095FRChG7epTLvTDUFSmei66yJFvJDdM-bscCj6_MMfX7z-tPm3Wr78e37zcV2ZddC1JVT3nHppeR87bGVXkAvGeZEcq8s8N71hg4tp5LGgmdMDQwII8QNQtKW_Ay9XLjzfpjAWYg1m1HPOUwmH3QyQd9-iWGnv6TvmnHZ03XfAE-vATl920OpegrFwjiaCGlfNME95VhJyZr02SK1bfeSwR_HEKx_Vaxbxfqq4qZ98nuuo_Km0yZ4tQjaIAdlCKnYAK26o_QqhNtBCSlqk2uwIyz0m3kNsv1vyK3QL_4Z18zkL2aKCd1cfMBY4kuiZ-ebhy-eEH3Kk_mR8uh0NYcxZZ_bRwpFsz9z_gTqKuLh</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Nikolaienko, Roman M.</creator><creator>Agyekum, Boadi</creator><creator>Bouyain, Samuel</creator><general>Taylor & Francis</general><general>Landes Bioscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120701</creationdate><title>Receptor protein tyrosine phosphatases and cancer</title><author>Nikolaienko, Roman M. ; Agyekum, Boadi ; Bouyain, Samuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>cell adhesion</topic><topic>Cell Communication</topic><topic>crystal structure</topic><topic>Cycle</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>inactivating somatic mutations</topic><topic>Landes</topic><topic>Models, Molecular</topic><topic>Mutation</topic><topic>Neoplasms - enzymology</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>oncogene</topic><topic>Organogenesis</topic><topic>phosphatase</topic><topic>phosphorylation</topic><topic>Protein Interaction Domains and Motifs</topic><topic>Protein Structure, Quaternary</topic><topic>Proteins</topic><topic>receptor overexpression</topic><topic>receptor protein tyrosine phosphatase</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - chemistry</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - genetics</topic><topic>Receptor-Like Protein Tyrosine Phosphatases - metabolism</topic><topic>Review</topic><topic>tumor suppressor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nikolaienko, Roman M.</creatorcontrib><creatorcontrib>Agyekum, Boadi</creatorcontrib><creatorcontrib>Bouyain, Samuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell adhesion & migration</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nikolaienko, Roman M.</au><au>Agyekum, Boadi</au><au>Bouyain, Samuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Receptor protein tyrosine phosphatases and cancer: New insights from structural biology</atitle><jtitle>Cell adhesion & migration</jtitle><addtitle>Cell Adh Migr</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>6</volume><issue>4</issue><spage>356</spage><epage>364</epage><pages>356-364</pages><issn>1933-6918</issn><eissn>1933-6926</eissn><abstract>There is general agreement that many cancers are associated with aberrant phosphotyrosine signaling, which can be caused by the inappropriate activities of tyrosine kinases or tyrosine phosphatases. Furthermore, incorrect activation of signaling pathways has been often linked to changes in adhesion events mediated by cell surface receptors. Among these receptors, receptor protein tyrosine phosphatases (RPTPs) both antagonize tyrosine kinases as well as engage extracellular ligands. A recent wealth of data on this intriguing family indicates that its members can fulfill either tumor suppressing or oncogenic roles. The interpretation of these results at a molecular level has been greatly facilitated by the recent availability of structural information on the extra- and intracellular regions of RPTPs. These structures provide a molecular framework to understand how alterations in extracellular interactions can inactivate RPTPs in cancers or why the overexpression of certain RPTPs may also participate in tumor progression.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>22796942</pmid><doi>10.4161/cam.21242</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1933-6918 |
ispartof | Cell adhesion & migration, 2012-07, Vol.6 (4), p.356-364 |
issn | 1933-6918 1933-6926 |
language | eng |
recordid | cdi_landesbioscience_primary_celladhesion_article_21242_10_4161 |
source | PubMed Central |
subjects | Animals Binding Biology Bioscience Calcium Cancer Cell cell adhesion Cell Communication crystal structure Cycle Gene Expression Humans inactivating somatic mutations Landes Models, Molecular Mutation Neoplasms - enzymology Neoplasms - genetics Neoplasms - pathology oncogene Organogenesis phosphatase phosphorylation Protein Interaction Domains and Motifs Protein Structure, Quaternary Proteins receptor overexpression receptor protein tyrosine phosphatase Receptor-Like Protein Tyrosine Phosphatases - chemistry Receptor-Like Protein Tyrosine Phosphatases - genetics Receptor-Like Protein Tyrosine Phosphatases - metabolism Review tumor suppressor |
title | Receptor protein tyrosine phosphatases and cancer: New insights from structural biology |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A52%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_lande&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Receptor%20protein%20tyrosine%20phosphatases%20and%20cancer:%20New%20insights%20from%20structural%20biology&rft.jtitle=Cell%20adhesion%20&%20migration&rft.au=Nikolaienko,%20Roman%20M.&rft.date=2012-07-01&rft.volume=6&rft.issue=4&rft.spage=356&rft.epage=364&rft.pages=356-364&rft.issn=1933-6918&rft.eissn=1933-6926&rft_id=info:doi/10.4161/cam.21242&rft_dat=%3Cproquest_lande%3E1082409773%3C/proquest_lande%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c566t-d9fd47f77445f0c7f6e87304174f9ce48d8a2b92697acef339b3e1311db672193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1082409773&rft_id=info:pmid/22796942&rfr_iscdi=true |